
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. (NMRA)
WebsitePrice
Market cap
Next catalystExpected 2H 2026NMRA-898 — Phase 1 SAD/MAD · Phase 1 dataCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved